Axon Enterprise (NASDAQ: AXON) delivered a revenue beat and raised full-year guidance on Tuesday, but a steep earnings miss and collapsing operating income sent the stock lower in after-hours trading. The public safety technology company reported Q3 revenue of $711.0 million, topping the $704.8 million consensus estimate, yet posted adjusted EPS of $1.17 against expectations of $1.54. Investors are weighing strong demand for TASER and body camera hardware against heavy R&D spending and tariff pressures that crushed near-term profitability.
Software Growth Accelerates, Hardware Follows
The real story here is segment momentum. Software & Services revenue surged 41% year-over-year to $305 million, outpacing Connected Devices growth of 24% to $405 million. That’s the clearest signal that the company’s transition toward higher-margin software and AI-driven analytics is taking hold. Strong demand for TASER 10 and Axon Body 4 devices kept hardware revenue robust despite a tougher operating environment.
Gross profit reached $427.3 million with a 60.1% margin, a healthy foundation. The company also doubled its cash position to $1.42 billion year-over-year, a sign of operational discipline and M&A appetite. Recent acquisitions of Prepared and Carbyne underscore management’s commitment to vertical integration in public safety software.
Operating Income Collapsed, Dragging Down Earnings
The earnings miss wasn’t about revenue shortfall. It was about cost structure. Operating income swung to a $2.1 million loss from a $24.4 million profit a year ago. GAAP net income turned negative at $2.2 million versus $67 million in the prior year quarter. Operating cash flow declined 34% to $60 million, reflecting the cash drag of restructuring and strategic investments.
Management flagged global tariffs as a headwind on gross margin, and heavy R&D spending is clearly pressuring near-term profitability. The company is investing aggressively in AI capabilities and software infrastructure, which makes strategic sense but leaves little room for near-term earnings surprises.
Key Figures
Revenue: $711.0M (vs. $704.8M estimate); up 31% year-over-year
Adjusted EPS: $1.17 (vs. $1.54 estimate); miss of $0.37
Gross Margin: 60.1%
Adjusted EBITDA: $177M with 24.9% margin
Operating Income: Loss of $2.1M vs. profit of $24.4M year-over-year
Operating Cash Flow: $60.0M; down 34% year-over-year
Free Cash Flow: $33.4M
Cash and Equivalents: $1.42B; up 105% year-over-year
I’d focus on the cash position and EBITDA margin. Despite the GAAP loss, adjusted EBITDA of $177 million shows the underlying business is generating real profit. The cash surge suggests the company is positioning for continued M&A while managing through this investment cycle.
Guidance Points to Sustained Momentum
Management raised full-year 2025 revenue guidance to approximately $2.74 billion, implying 31% annual growth. Q4 guidance calls for revenue between $750 million and $755 million with adjusted EBITDA margin around 24%. That’s confidence in the forward trajectory, even if near-term profitability remains under pressure.
The outlook suggests management believes tariff impacts will stabilize and that software revenue acceleration will continue. If they execute on guidance, the full-year growth story remains intact despite this quarter’s operating income headwind.
What Investors Should Watch Next
Listen closely during the earnings call for commentary on tariff timing and mitigation. If management can stabilize gross margin and demonstrate that R&D spending is beginning to translate into software revenue acceleration, the narrative around this miss shifts quickly. Watch Q4 for evidence that operating leverage is returning. The valuation is stretched, so execution on both revenue and margin recovery will matter more than ever.